The Lancet: Major progress against hepatitis C by 2030 is possible, but will need vast improvements in screening, prevention and treatment
(The Lancet) A comprehensive package of prevention, screening, and treatment interventions could avert 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths globally by 2030 -- equal to an 80 percent reduction in incidence and a 60 percent reduction in deaths compared with 2015, according to the first study to model hepatitis C interventions globally published in The Lancet.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
More News: Cancer | Cancer & Oncology | Cirrhosis | Hepatitis | Hepatitis C | International Medicine & Public Health | Liver | Science | Study | Urology & Nephrology